Bacterial acne foam - Foamix/Warner Chilcott

Drug Profile

Bacterial acne foam - Foamix/Warner Chilcott

Latest Information Update: 05 Jun 2013

Price : $50

At a glance

  • Originator Foamix; Warner Chilcott
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Acne

Most Recent Events

  • 05 Jun 2013 No development reported - Preclinical for Acne in Israel (Topical)
  • 12 Jan 2007 Preclinical trials in Acne in Israel (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top